Vertex Pharmaceuticals Incorporated (VRTX) Stock Price Today
Aura AI Summary
Key Stats
- $130.90BMarket Cap
- -Volume
- HealthSector
- $529.6552W High
- $376.6252W Low
- -Typical Hold Time
- $125.02BEnterprise Value
- -Div Yield
- -Trading Activity
Track Vertex Pharmaceuticals Incorporated (VRTX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vertex Pharmaceuticals Incorporated has traded between a low of $376.62 and a high of $529.65, highlighting its annual price range. Buy and sell Vertex Pharmaceuticals Incorporated shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Most Recent News
Rubrik director Yvonne Wassenaar sold 721 shares at $75 before stock rally began.
Yvonne Wassenaar, a director at Rubrik, sold 721 shares at a price of $75 each just before the company's stock experienced a significant rally. This sale occurred ahead of the stock's upward movement, which may be of interest to investors tracking in...
Meta launches open AI model Glimmer amid $250M deal fallout involving forged documents and lawsuits
Meta released Glimmer, an open-weight AI model available for anyone to run on their hardware, contrasting with its more restricted Muse Spark model. This launch coincides with Mark Zuckerberg's call for AI to be accessible to all, not just controlled...
Rivian's $23B market cap outpaces Stellantis despite selling far fewer cars, highlighting EV market hype.
Rivian, an electric vehicle (EV) maker, has a market cap of $23 billion, surpassing global car giant Stellantis, which is valued at $20 billion despite selling millions more vehicles. Rivian expects to sell 65,000 to 70,000 vehicles this year, while ...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.